Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för B Lynne Parshall. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att B Lynne Parshall har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:IONS / Ionis Pharmaceuticals, Inc. | Director | 66 344 |
US:CYTK / Cytokinetics, Incorporated | Director | 27 933 |
Director | 0 | |
US:RGLS / Regulus Therapeutics Inc. | Director | 5 516 305 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av B Lynne Parshall. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp CYTK / Cytokinetics, Incorporated - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CYTK / Cytokinetics, Incorporated. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CYTK / Cytokinetics, Incorporated. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp IONS / Ionis Pharmaceuticals, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CYTK / Cytokinetics, Incorporated. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CYTK / Cytokinetics, Incorporated. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av B Lynne Parshall som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 250 | 66 344 | −12,24 | 51,49 | −476 282 | 3 416 053 |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 750 | 75 594 | −12,45 | 50,42 | −542 015 | 3 811 449 |
2025-08-08 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 86 344 | −0,46 | 42,63 | −17 051 | 3 680 629 |
2025-08-08 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 600 | 86 744 | −5,04 | 41,87 | −192 595 | 3 631 841 |
2025-07-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 079 | 91 344 | 4,67 | ||||
2025-05-15 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
A - Award | 7 333 | 27 933 | 35,60 | ||||
2024-09-09 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | −5 000 | 20 600 | −19,53 | 54,92 | −274 600 | 1 131 352 | |
2024-09-09 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | 5 000 | 25 600 | 24,27 | 21,61 | 108 050 | 553 216 | |
2024-08-26 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | −5 000 | 20 600 | −19,53 | 57,26 | −286 300 | 1 179 556 | |
2024-08-26 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | 5 000 | 25 600 | 24,27 | 21,61 | 108 050 | 553 216 | |
2024-08-12 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | −5 000 | 20 600 | −19,53 | 55,20 | −276 000 | 1 137 120 | |
2024-08-12 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | 5 000 | 25 600 | 24,27 | 21,61 | 108 050 | 553 216 | |
2024-07-31 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | −5 000 | 20 600 | −19,53 | 59,84 | −299 200 | 1 232 704 | |
2024-07-31 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | 5 000 | 25 600 | 24,27 | 21,61 | 108 050 | 553 216 | |
2024-07-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 677 | 87 265 | 5,66 | ||||
2024-07-16 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | −5 000 | 20 600 | −19,53 | 55,82 | −279 100 | 1 149 892 | |
2024-07-16 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | 5 000 | 25 600 | 24,27 | 10,68 | 53 400 | 273 408 | |
2024-07-01 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | −5 000 | 20 600 | −19,53 | 54,22 | −271 100 | 1 116 932 | |
2024-07-01 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | 5 000 | 25 600 | 24,27 | 10,68 | 53 400 | 273 408 | |
2024-06-17 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | −5 000 | 20 600 | −19,53 | 52,55 | −262 750 | 1 082 530 | |
2024-06-17 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | 5 000 | 25 600 | 24,27 | 10,68 | 53 400 | 273 408 | |
2024-06-04 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | −5 000 | 15 600 | −24,27 | 48,64 | −243 200 | 758 784 | |
2024-06-04 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | 5 000 | 20 600 | 32,05 | 10,68 | 53 400 | 220 008 | |
2024-05-16 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
A - Award | 5 600 | 20 600 | 37,33 | ||||
2023-12-28 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −42 525 | 82 588 | −33,99 | 50,19 | −2 134 223 | 4 144 885 | |
2023-12-28 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 42 525 | 125 113 | 51,49 | 47,34 | 2 013 134 | 5 922 849 | |
2023-12-28 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −50 000 | 82 588 | −37,71 | 50,23 | −2 511 515 | 4 148 420 | |
2023-12-28 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 50 000 | 132 588 | 60,54 | 47,34 | 2 367 000 | 6 276 716 | |
2023-12-28 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −25 113 | 82 588 | −23,32 | 51,46 | −1 292 390 | 4 250 226 | |
2023-12-28 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 25 113 | 107 701 | 30,41 | 47,34 | 1 188 849 | 5 098 565 | |
2023-09-28 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 82 588 | −10,80 | 45,13 | −451 268 | 3 726 932 |
2023-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 333 | 92 588 | 6,11 | ||||
2023-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 777 | 87 255 | 2,08 | ||||
2023-05-18 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
A - Award | 5 000 | 15 000 | 50,00 | ||||
2022-09-01 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | X | −30 296 | 10 000 | −75,18 | 52,79 | −1 599 326 | 527 900 |
2022-09-01 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | X | 4 582 | 40 296 | 12,83 | 6,82 | 31 249 | 274 819 |
2022-09-01 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | X | 20 000 | 35 714 | 127,28 | 9,45 | 189 000 | 337 497 |
2022-09-01 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | X | 5 714 | 15 714 | 57,14 | 8,75 | 49 998 | 137 498 |
2022-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 665 | 85 478 | 3,22 | ||||
2022-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 333 | 82 813 | 6,88 | ||||
2022-05-11 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2022-05-11 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
A - Award | 5 000 | 10 000 | 100,00 | ||||
2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −5 754 | 9 775 | −37,05 | ||||
2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −1 652 | 77 480 | −2,09 | 30,12 | −49 758 | 2 333 698 | |
2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 754 | 79 132 | 7,84 | ||||
2021-11-05 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −20 000 | 0 | −100,00 | |||
2021-11-05 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −4 032 | 0 | −100,00 | |||
2021-11-05 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 798 | 0 | −100,00 | |||
2021-11-05 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −4 166 | 0 | −100,00 | |||
2021-11-05 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | X | −2 798 | 5 000 | −35,88 | 40,00 | −111 920 | 200 000 |
2021-11-05 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | X | 2 798 | 7 798 | 55,96 | 6,84 | 19 138 | 53 338 |
2021-11-05 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | X | −4 166 | 5 000 | −45,45 | 40,00 | −166 640 | 200 000 |
2021-11-05 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | X | 4 166 | 9 166 | 83,32 | 6,78 | 28 245 | 62 145 |
2021-11-05 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | X | −4 032 | 5 000 | −44,64 | 40,00 | −161 280 | 200 000 |
2021-11-05 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | X | 4 032 | 9 032 | 80,64 | 12,40 | 49 997 | 111 997 |
2021-11-05 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | X | −20 000 | 5 000 | −80,00 | 40,00 | −800 000 | 200 000 |
2021-11-05 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | X | 20 000 | 25 000 | 400,00 | 14,25 | 285 000 | 356 250 |
2021-10-20 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 999 | 2 798 | −41,67 | |||
2021-10-20 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −8 333 | 0 | −100,00 | |||
2021-10-20 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | X | −8 333 | 5 000 | −62,50 | 35,73 | −297 774 | 178 672 |
2021-10-20 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | X | 8 333 | 13 333 | 166,66 | 6,60 | 54 998 | 87 998 |
2021-10-20 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | X | −1 999 | 5 000 | −28,56 | 35,73 | −71 433 | 178 672 |
2021-10-20 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | X | 1 999 | 6 999 | 39,98 | 6,84 | 13 673 | 47 873 |
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −1 778 | 15 529 | −10,27 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −889 | 17 307 | −4,89 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −5 333 | 18 196 | −22,67 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 778 | 73 378 | 2,48 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 889 | 71 600 | 1,26 | ||||
2021-07-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 333 | 70 711 | 8,16 | ||||
2021-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
A - Award | 5 333 | 23 529 | 29,31 | ||||
2021-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | |||||
2021-05-13 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2021-05-13 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
A - Award | 5 000 | 5 000 | |||||
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −10 655 | 5 754 | −64,93 | ||||
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −2 741 | 65 378 | −4,02 | 61,28 | −167 968 | 4 006 364 | |
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 655 | 68 119 | 18,54 | ||||
2020-12-28 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 57 464 | −14,82 | 60,00 | −600 000 | 3 447 840 |
2020-11-30 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 590 | 0 | −100,00 | ||||
2020-11-30 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 590 | 67 464 | −5,05 | 50,05 | −179 680 | 3 376 573 |
2020-11-30 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 590 | 71 054 | 5,32 | 39,87 | 143 133 | 2 832 923 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −710 | 3 590 | −16,51 | ||||
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −710 | 67 464 | −1,04 | 50,82 | −36 082 | 3 428 520 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 710 | 68 174 | 1,05 | 39,87 | 28 308 | 2 718 097 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 200 | 4 300 | −42,67 | ||||
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 200 | 67 464 | −4,53 | 50,12 | −160 384 | 3 381 296 |
2020-11-25 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 200 | 70 664 | 4,74 | 39,87 | 127 584 | 2 817 374 |
2020-10-13 |
|
4 | AKCA |
AKCEA THERAPEUTICS, INC.
Stock Option (right to buy) |
D - Sale to Issuer | −26 400 | 0 | −100,00 | 2,01 | −53 064 | ||
2020-10-06 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −4 375 | 0 | −100,00 | 4,00 | −17 500 | |
2020-10-06 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −20 000 | 0 | −100,00 | |||
2020-10-06 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −20 000 | 0 | −100,00 | |||
2020-10-06 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −5 936 | 0 | −100,00 | |||
2020-10-06 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | X | −5 936 | 0 | −100,00 | 30,00 | −178 080 | |
2020-10-06 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | X | 5 936 | 5 936 | 7,37 | 43 748 | 43 748 | |
2020-10-06 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | X | −20 000 | 0 | −100,00 | 30,00 | −600 000 | |
2020-10-06 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | X | −20 000 | 0 | −100,00 | 30,00 | −600 000 | |
2020-10-06 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | X | 20 000 | 20 000 | 6,21 | 124 200 | 124 200 | |
2020-10-06 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | X | −4 375 | 0 | −100,00 | 30,00 | −131 250 | |
2020-10-06 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | X | 4 375 | 4 375 | 10,00 | 43 750 | 43 750 | |
2020-10-06 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | X | 20 000 | 20 000 | 7,61 | 152 200 | 152 200 | |
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −889 | 1 777 | −33,35 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 889 | 67 464 | 1,34 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | |||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 5 333 | 5 333 | |||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 778 | 5 332 | −25,01 | ||||
2020-07-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 778 | 66 575 | 2,74 | ||||
2020-06-23 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 510 | 0 | −100,00 | ||||
2020-06-23 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2020-06-23 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | −6 510 | 0 | −100,00 | 25,00 | −162 750 | ||
2020-06-23 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | 6 510 | 6 510 | 6,72 | 43 747 | 43 747 | ||
2020-06-23 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
S - Sale | −10 000 | 0 | −100,00 | 25,00 | −250 000 | ||
2020-06-23 |
|
4 | CYTK |
CYTOKINETICS INC
Common Stock |
M - Exercise | 10 000 | 10 000 | 4,44 | 44 400 | 44 400 | ||
2020-05-14 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | 21,61 | 432 200 | 432 200 | ||
2020-04-15 |
|
4 | AKCA |
AKCEA THERAPEUTICS, INC.
Stock Option (right to buy) |
A - Award | 26 400 | 26 400 | |||||
2020-02-14 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2 749 | 2 749 | 15,43 | 42 417 | 42 417 | ||
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −15 136 | 16 409 | −47,98 | ||||
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −3 905 | 64 797 | −5,68 | 62,06 | −242 344 | 4 021 302 | |
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15 136 | 68 702 | 28,26 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −889 | 2 666 | −25,01 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 889 | 53 566 | 1,69 | ||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 16 000 | 16 000 | |||||
2019-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 7 110 | 7 110 | |||||
2019-06-18 |
|
4 | AKCA |
AKCEA THERAPEUTICS, INC.
Stock Option (right to buy) |
A - Award | 26 400 | 26 400 | |||||
2019-05-17 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | 10,68 | 213 600 | 213 600 | ||
2019-05-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 50 000 | 7 500 | −117,65 | ||||
2019-05-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −50 000 | 52 677 | −48,70 | 75,01 | −3 750 635 | 3 951 444 |
2019-05-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 50 000 | 102 677 | 94,92 | 39,87 | 1 993 500 | 4 093 732 |
2019-03-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 8 334 | 57 500 | 16,95 | ||||
2019-03-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 334 | 52 677 | −13,66 | 75,00 | −625 050 | 3 950 775 |
2019-03-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 334 | 61 011 | 15,82 | 39,87 | 332 277 | 2 432 509 |
2019-03-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 8 333 | 65 834 | 14,49 | ||||
2019-03-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 333 | 52 677 | −13,66 | 70,00 | −583 310 | 3 687 390 |
2019-03-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 333 | 61 010 | 15,82 | 39,87 | 332 237 | 2 432 469 |
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −20 656 | 35 100 | −37,05 | ||||
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −6 159 | 52 677 | −10,47 | 58,26 | −358 823 | 3 068 962 | |
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 20 656 | 58 836 | 54,10 | ||||
2019-01-04 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 4 582 | 4 582 | 6,82 | 31 249 | 31 249 | ||
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Director Stock Option (right to buy) |
A - Award | 16 000 | 16 000 | |||||
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 3 555 | 3 555 | |||||
2018-06-05 |
|
4 | AKCA |
AKCEA THERAPEUTICS, INC.
Stock Option (right to buy) |
A - Award | 26 400 | 26 400 | |||||
2018-05-17 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | 9,45 | 189 000 | 189 000 | ||
2018-05-08 |
|
4 | AKCA |
AKCEA THERAPEUTICS, INC.
Stock Option (right to buy) |
A - Award | 53 000 | 53 000 | |||||
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −5 986 | 38 180 | −13,55 | 51,76 | −309 835 | 1 976 197 | |
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −18 339 | 29 185 | −38,59 | ||||
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 23 016 | 23 016 | |||||
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 18 339 | 44 166 | 71,01 | ||||
2018-01-04 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 5 714 | 5 714 | 3,50 | 20 000 | 20 000 | ||
2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 103 575 | 103 575 | |||||
2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 86 | 25 827 | 0,33 | 42,76 | 3 677 | 1 104 233 | |
2017-10-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −8 333 | 74 167 | −10,10 | ||||
2017-10-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −7 785 | 0 | −100,00 | ||||
2017-10-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 333 | 25 741 | −24,46 | 65,00 | −541 645 | 1 673 165 |
2017-10-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 333 | 34 074 | 32,37 | 39,87 | 332 237 | 1 358 530 |
2017-10-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 785 | 25 741 | −23,22 | 65,00 | −506 025 | 1 673 165 |
2017-10-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 785 | 33 526 | 30,24 | 14,69 | 114 362 | 492 497 |
2017-07-13 | 3 | AKCA |
AKCEA THERAPEUTICS, INC.
No securities are beneficially owned. |
0 | ||||||||
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 90 | 25 741 | 0,35 | 40,66 | 3 659 | 1 046 513 | |
2017-05-22 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2017-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −4 625 | 7 785 | −37,27 | ||||
2017-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 625 | 25 651 | −15,28 | 49,26 | −227 828 | 1 263 568 |
2017-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 625 | 30 276 | 18,03 | 14,69 | 67 941 | 444 754 |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 076 | 25 651 | −7,49 | 46,29 | −96 097 | 1 187 367 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 696 | 23 245 | −10,39 | 46,29 | −124 796 | 1 075 999 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 509 | 20 422 | −6,88 | 46,29 | −69 851 | 945 324 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −965 | 18 494 | −4,96 | 46,29 | −44 670 | 856 091 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −4 482 | 13 443 | −25,00 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 519 | 11 038 | −33,33 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −3 437 | 3 437 | −50,00 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −2 595 | 0 | −100,00 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 19 606 | 19 606 | |||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 482 | 27 727 | 19,28 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 519 | 25 941 | 27,02 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 437 | 21 931 | 18,58 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 595 | 19 459 | 15,39 | ||||
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 117 638 | 117 638 | |||||
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 171 | 16 864 | 1,02 | 20,76 | 3 549 | 350 046 | |
2017-01-04 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 4 032 | 4 032 | 4,96 | 20 000 | 20 000 | ||
2016-12-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 000 | 20 693 | 5,08 | 7,25 | 7 250 | 150 024 | |
2016-12-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 000 | 20 693 | −4,61 | 50,00 | −50 000 | 1 034 650 | |
2016-12-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 0 | −100,00 | ||||
2016-12-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 0 | −100,00 | ||||
2016-12-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 0 | −100,00 | ||||
2016-12-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 000 | 0 | −100,00 | ||||
2016-12-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 50,00 | −50 000 | |
2016-12-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 50,00 | −50 000 | |
2016-12-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 50,00 | −50 000 | |
2016-12-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 1 000 | 7,25 | 7 250 | 7 250 | |
2016-12-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 1 000 | 7,25 | 7 250 | 7 250 | |
2016-12-16 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 1 000 | 7,25 | 7 250 | 7 250 | |
2016-12-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −12 500 | 12 410 | −50,18 | ||||
2016-12-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 500 | 16 693 | −24,78 | 43,17 | −237 435 | 720 637 |
2016-12-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 500 | 22 193 | 32,95 | 14,69 | 80 795 | 326 015 |
2016-12-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 000 | 16 693 | −29,54 | 41,49 | −290 430 | 692 593 |
2016-12-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 000 | 23 693 | 41,93 | 14,69 | 102 830 | 348 050 |
2016-09-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −3 635 | 24 910 | −12,73 | ||||
2016-09-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Options (right to buy) |
M - Exercise | −8 865 | 0 | −100,00 | ||||
2016-09-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 635 | 16 693 | −17,88 | 30,05 | −109 232 | 501 625 |
2016-09-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 635 | 20 328 | 21,78 | 14,69 | 53 398 | 298 618 |
2016-09-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 865 | 16 693 | −34,69 | 29,82 | −264 314 | 497 708 |
2016-09-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 865 | 25 558 | 53,11 | 7,25 | 64 271 | 185 296 |
2016-07-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 403 | 16 693 | 2,47 | 20,76 | 8 365 | 346 497 | |
2016-05-20 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 303 | 16 290 | −12,39 | 41,46 | −95 479 | 675 357 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 219 | 13 074 | −8,53 | 41,46 | −50 534 | 541 991 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 003 | 10 855 | −8,46 | 41,47 | −41 590 | 450 111 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −667 | 9 263 | −6,72 | 41,46 | −27 653 | 384 038 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 519 | 16 557 | −25,00 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −3 438 | 6 874 | −33,34 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −2 595 | 2 595 | −50,00 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 715 | 0 | −100,00 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 17 925 | 17 925 | |||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 519 | 18 593 | 42,21 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 438 | 14 293 | 31,67 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 595 | 11 858 | 28,01 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 715 | 9 930 | 20,88 | ||||
2016-01-06 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 4 375 | 4 375 | 4,00 | 17 500 | 17 500 | ||
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −809 | 28 545 | −2,76 | ||||
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 107 549 | 107 549 | |||||
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −809 | 8 215 | −8,96 | 61,05 | −49 389 | 501 526 |
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 809 | 9 024 | 9,85 | 14,69 | 11 884 | 132 563 |
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 72 | 8 215 | 0,88 | 47,71 | 3 435 | 391 942 | |
2015-11-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 1 000 | 1 000 | |||||
2015-11-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 1 000 | 1 000 | |||||
2015-11-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 1 000 | 1 000 | |||||
2015-11-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 1 000 | 1 000 | |||||
2015-11-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | −4 000 | 8 865 | −31,09 | ||||
2015-10-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 436 | 29 354 | −15,63 | ||||
2015-10-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 436 | 8 143 | −29,67 | 42,39 | −145 667 | 345 218 |
2015-10-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 436 | 11 579 | 42,20 | 14,69 | 50 475 | 170 096 |
2015-10-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 8 143 | −19,72 | 40,10 | −80 200 | 326 534 |
2015-10-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 10 143 | 24,56 | 14,69 | 29 380 | 149 001 |
2015-10-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 838 | 34 790 | −7,54 | ||||
2015-10-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −4 162 | 12 865 | −24,44 | ||||
2015-10-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 838 | 8 143 | −25,84 | 40,13 | −113 877 | 326 744 |
2015-10-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 838 | 10 981 | 34,85 | 14,69 | 41 690 | 161 311 |
2015-10-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 162 | 8 143 | −33,82 | 40,13 | −167 003 | 326 744 |
2015-10-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 162 | 12 305 | 51,11 | 7,25 | 30 174 | 89 211 |
2015-07-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −4 843 | 17 027 | −22,14 | ||||
2015-07-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 375 | 0 | −100,00 | ||||
2015-07-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 843 | 8 143 | −37,29 | 57,01 | −276 085 | 464 208 |
2015-07-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 843 | 12 986 | 59,47 | 7,25 | 35 112 | 94 148 |
2015-07-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 375 | 8 143 | −14,45 | 57,01 | −78 385 | 464 208 |
2015-07-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 375 | 9 518 | 16,89 | 10,29 | 14 149 | 97 940 |
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −6 218 | 1 375 | −81,89 | ||||
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 218 | 8 143 | −43,30 | 57,56 | −357 914 | 468 719 |
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 218 | 14 361 | 76,36 | 10,29 | 63 983 | 147 775 |
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 71 | 8 143 | 0,88 | 48,59 | 3 450 | 395 636 | |
2015-05-21 |
|
4 | CYTK |
CYTOKINETICS INC
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2015-04-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 565 | 37 628 | −12,88 | ||||
2015-04-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 565 | 8 072 | −40,81 | 63,07 | −350 990 | 509 109 |
2015-04-08 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 565 | 13 637 | 68,94 | 14,69 | 81 750 | 200 328 |
2015-04-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 377 | 43 193 | −11,07 | ||||
2015-04-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 377 | 8 072 | −39,98 | 61,93 | −333 009 | 499 916 |
2015-04-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 377 | 13 449 | 66,61 | 14,69 | 78 988 | 197 566 |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 818 | 8 072 | −18,38 | 67,96 | −123 559 | 548 605 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 372 | 6 452 | −17,54 | 67,96 | −93 247 | 438 504 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −903 | 5 229 | −14,73 | 67,96 | −61 371 | 355 384 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −3 438 | 10 312 | −25,00 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −2 595 | 5 190 | −33,33 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 715 | 1 715 | −50,00 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 22 076 | 22 076 | |||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 438 | 9 890 | 53,29 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 595 | 7 824 | 49,63 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 715 | 6 132 | 38,83 | ||||
2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −11 200 | 48 570 | −18,74 | ||||
2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 132 458 | 132 458 | |||||
2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 200 | 4 417 | −71,72 | 62,12 | −695 688 | 274 362 |
2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 11 200 | 15 617 | 253,57 | 14,69 | 164 528 | 229 414 |
2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 111 | 4 417 | 2,58 | 30,05 | 3 335 | 132 720 | |
2015-01-05 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 5 936 | 5 936 | 2,95 | 17 511 | 17 511 | ||
2014-11-05 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | −1 279 411 | 5 516 305 | −18,83 | 15,94 | −20 390 613 | 87 916 111 | |
2014-10-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −8 561 | 21 870 | −28,13 | ||||
2014-10-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 510 | 59 770 | −4,03 | ||||
2014-10-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 561 | 4 306 | −66,53 | 45,12 | −386 281 | 194 291 |
2014-10-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 561 | 12 867 | 198,82 | 7,25 | 62 067 | 93 286 |
2014-10-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 510 | 4 306 | −36,83 | 45,12 | −113 254 | 194 291 |
2014-10-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 510 | 6 816 | 58,29 | 14,69 | 36 872 | 100 127 |
2014-10-24 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 850 | 6 795 716 | −0,03 | 15,19 | −28 109 | 103 256 148 |
2014-10-24 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 700 | 6 797 566 | −0,03 | 14,24 | −24 202 | 96 774 908 |
2014-10-24 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −109 534 | 6 799 266 | −1,59 | 14,00 | −1 533 125 | 95 167 966 |
2014-10-17 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −3 000 | 6 908 800 | −0,04 | 6,79 | −20 371 | 46 912 825 |
2014-10-17 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −4 800 | 6 911 800 | −0,07 | 6,76 | −32 450 | 46 727 224 |
2014-10-17 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −4 300 | 6 916 600 | −0,06 | 6,67 | −28 687 | 46 143 405 |
2014-10-10 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −2 000 | 6 920 900 | −0,03 | 6,41 | −12 813 | 44 337 362 |
2014-10-10 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −4 750 | 6 922 900 | −0,07 | 6,58 | −31 238 | 45 527 760 |
2014-10-10 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −3 300 | 6 927 650 | −0,05 | 6,63 | −21 888 | 45 948 331 |
2014-10-03 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −3 300 | 6 930 950 | −0,05 | 6,88 | −22 688 | 47 650 974 |
2014-10-03 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −3 750 | 6 934 250 | −0,05 | 6,64 | −24 903 | 46 048 274 |
2014-10-03 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −3 250 | 6 938 000 | −0,05 | 6,71 | −21 808 | 46 556 061 |
2014-09-26 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −2 500 | 6 941 250 | −0,04 | 7,04 | −17 598 | 48 861 541 |
2014-09-26 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −2 500 | 6 943 750 | −0,04 | 7,12 | −17 790 | 49 411 725 |
2014-09-26 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −3 750 | 6 946 250 | −0,05 | 7,19 | −26 978 | 49 972 712 |
2014-09-19 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −4 100 | 6 950 000 | −0,06 | 7,22 | −29 587 | 50 153 285 |
2014-09-19 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 500 | 6 954 100 | −0,02 | 7,40 | −11 098 | 51 449 213 |
2014-09-19 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −2 100 | 6 955 600 | −0,03 | 7,43 | −15 610 | 51 701 670 |
2014-09-12 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −3 500 | 6 957 700 | −0,05 | 7,96 | −27 861 | 55 384 684 |
2014-09-12 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −3 400 | 6 961 200 | −0,05 | 7,83 | −26 636 | 54 534 737 |
2014-09-12 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −2 000 | 6 964 600 | −0,03 | 7,70 | −15 399 | 53 624 634 |
2014-09-05 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −2 400 | 6 966 600 | −0,03 | 7,07 | −16 974 | 49 272 672 |
2014-09-05 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −6 000 | 6 969 000 | −0,09 | 7,11 | −42 656 | 49 545 409 |
2014-09-05 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 650 | 6 975 000 | −0,02 | 6,95 | −11 471 | 48 489 502 |
2014-09-04 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −443 | 30 431 | −1,43 | ||||
2014-09-04 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 628 | 7 593 | −58,33 | ||||
2014-09-04 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −443 | 4 306 | −9,33 | 40,24 | −17 827 | 173 277 |
2014-09-04 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 443 | 4 749 | 10,29 | 7,25 | 3 212 | 34 430 |
2014-09-04 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 628 | 4 306 | −71,17 | 40,24 | −427 680 | 173 277 |
2014-09-04 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 628 | 14 934 | 246,82 | 10,29 | 109 362 | 153 671 |
2014-08-29 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 500 | 6 976 650 | −0,02 | 6,84 | −10 254 | 47 692 379 |
2014-08-29 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −2 000 | 6 978 150 | −0,03 | 6,96 | −13 921 | 48 570 715 |
2014-08-29 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 500 | 6 980 150 | −0,02 | 7,21 | −10 821 | 50 356 896 |
2014-08-22 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −5 250 | 6 981 650 | −0,08 | 6,75 | −35 443 | 47 133 119 |
2014-08-22 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −2 500 | 6 986 900 | −0,04 | 6,89 | −17 222 | 48 132 055 |
2014-08-22 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −3 000 | 6 989 400 | −0,04 | 7,14 | −21 424 | 49 912 703 |
2014-08-15 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 450 | 6 992 400 | −0,02 | 6,98 | −10 115 | 48 779 682 |
2014-08-15 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 750 | 6 993 850 | −0,03 | 7,04 | −12 324 | 49 252 790 |
2014-08-15 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −2 250 | 6 995 600 | −0,03 | 7,02 | −15 788 | 49 086 027 |
2014-08-08 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 850 | 6 997 850 | −0,03 | 6,80 | −12 583 | 47 595 177 |
2014-08-08 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −2 600 | 6 999 700 | −0,04 | 6,66 | −17 322 | 46 634 101 |
2014-08-08 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −3 150 | 7 002 300 | −0,04 | 7,08 | −22 300 | 49 572 083 |
2014-08-01 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −2 600 | 7 005 450 | −0,04 | 6,21 | −16 152 | 43 521 358 |
2014-08-01 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 750 | 7 008 050 | −0,02 | 6,42 | −11 235 | 44 990 279 |
2014-08-01 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 000 | 7 009 800 | −0,01 | 6,60 | −6 602 | 46 279 401 |
2014-07-25 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 700 | 7 010 800 | −0,02 | 6,55 | −11 137 | 45 927 050 |
2014-07-25 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 850 | 7 012 500 | −0,03 | 6,81 | −12 598 | 47 753 021 |
2014-07-25 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 700 | 7 014 350 | −0,02 | 6,88 | −11 702 | 48 283 278 |
2014-07-18 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −5 000 | 7 016 050 | −0,07 | 6,80 | −34 001 | 47 710 543 |
2014-07-18 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −5 000 | 7 021 050 | −0,07 | 6,58 | −32 906 | 46 206 934 |
2014-07-18 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −3 500 | 7 026 050 | −0,05 | 6,59 | −23 058 | 46 288 320 |
2014-07-11 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 750 | 7 029 550 | −0,02 | 6,48 | −11 339 | 45 549 375 |
2014-07-11 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −4 500 | 7 031 300 | −0,06 | 6,69 | −30 109 | 47 045 022 |
2014-07-11 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 800 | 7 035 800 | −0,03 | 7,08 | −12 748 | 49 830 350 |
2014-07-07 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 200 | 7 037 600 | −0,02 | 8,07 | −9 678 | 56 760 355 |
2014-07-07 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −3 100 | 7 038 800 | −0,04 | 8,07 | −25 011 | 56 789 038 |
2014-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 284 | 4 306 | 7,06 | 30,20 | 8 577 | 130 043 | |
2014-06-27 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −3 150 | 7 041 900 | −0,04 | 7,91 | −24 931 | 55 733 822 |
2014-06-27 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −1 700 | 7 045 050 | −0,02 | 7,89 | −13 408 | 55 564 309 |
2014-06-27 |
|
4 | "RGLS" |
Regulus Therapeutics Inc.
Common Stock |
S - Sale | X | −2 750 | 7 046 750 | −0,04 | 7,84 | −21 566 | 55 261 318 |
2014-05-22 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −15 875 | 30 874 | −33,96 | ||||
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −23 635 | 18 221 | −56,47 | ||||
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 875 | 4 022 | −79,79 | 50,36 | −799 528 | 202 564 |
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 875 | 19 897 | 394,70 | 7,25 | 115 094 | 144 253 |
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −23 635 | 4 022 | −85,46 | 50,36 | −1 190 353 | 202 564 |
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 23 635 | 27 657 | 587,64 | 10,29 | 243 204 | 284 591 |
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −31 028 | 41 856 | −42,57 | ||||
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −3 972 | 0 | −100,00 | ||||
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 48,81 | −244 035 | |
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 48,81 | −244 035 | |
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 7,25 | 36 250 | 36 250 | |
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 7,25 | 36 250 | 36 250 | |
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 7,25 | 36 250 | 36 250 | |
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 48,81 | −244 035 | |
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −31 028 | 4 022 | −88,52 | 48,81 | −1 514 384 | 196 302 |
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 31 028 | 35 050 | 771,46 | 10,29 | 319 278 | 360 664 |
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 972 | 4 022 | −49,69 | 48,81 | −193 861 | 196 302 |
2014-01-31 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 972 | 7 994 | 98,76 | 11,27 | 44 764 | 90 092 |
2014-01-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 5 000 | 5 000 | |||||
2014-01-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | −5 000 | 46 749 | −9,66 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −988 | 4 022 | −19,72 | 47,08 | −46 518 | 189 366 | |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −653 | 2 415 | −21,28 | 47,08 | −30 745 | 113 704 | |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −2 595 | 7 785 | −25,00 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 715 | 3 430 | −33,33 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 13 750 | 13 750 | |||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 595 | 5 010 | 107,45 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 715 | 3 068 | 126,76 | ||||
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 82 500 | 82 500 | |||||
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 5 000 | 5 000 | |||||
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 5 000 | 5 000 | |||||
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | −10 000 | 51 749 | −16,19 | ||||
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 397 | 1 353 | 41,53 | 24,20 | 9 607 | 32 742 | |
2014-01-03 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 6 510 | 6 510 | 2,69 | 17 512 | 17 512 | ||
2013-12-30 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −37 811 | 3 972 | −90,49 | ||||
2013-12-30 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −37 811 | 956 | −97,53 | 40,91 | −1 546 772 | 39 108 |
2013-12-30 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 37 811 | 38 767 | 3 955,13 | 11,27 | 426 130 | 436 904 |
2013-12-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −20 000 | 41 783 | −32,37 | ||||
2013-12-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 000 | 956 | −95,44 | 41,00 | −819 920 | 39 192 |
2013-12-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 000 | 20 956 | 2 092,05 | 11,27 | 225 400 | 236 174 |
2013-12-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 771 | 61 783 | −2,79 | ||||
2013-12-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −48 229 | 0 | −100,00 | ||||
2013-12-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 771 | 956 | −64,94 | 41,68 | −73 817 | 39 847 |
2013-12-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 771 | 2 727 | 185,25 | 11,27 | 19 959 | 30 733 |
2013-12-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −48 229 | 956 | −98,06 | 41,68 | −2 010 233 | 39 847 |
2013-12-24 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 48 229 | 49 185 | 5 044,87 | 14,47 | 697 874 | 711 707 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 48 229 | −38,35 | ||||
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 956 | −91,27 | 35,90 | −358 980 | 34 318 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 10 956 | 1 046,03 | 15,38 | 153 800 | 168 503 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 956 | −96,91 | 35,90 | −1 076 940 | 34 318 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 30 956 | 3 138,08 | 14,47 | 434 100 | 447 933 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 0 | −100,00 | ||||
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −20 000 | 10 000 | −66,67 | ||||
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 956 | −96,91 | 35,02 | −1 050 600 | 33 479 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 30 956 | 3 138,08 | 16,45 | 493 500 | 509 226 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 000 | 956 | −95,44 | 35,12 | −702 480 | 33 579 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 000 | 20 956 | 2 092,05 | 15,38 | 307 600 | 322 303 |
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −1 520 | 30 000 | −4,82 | ||||
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 985 | 956 | −67,49 | 31,18 | −61 894 | 29 809 |
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 520 | 2 941 | −34,07 | 31,18 | −47 395 | 91 703 |
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 520 | 4 461 | 51,68 | 15,38 | 23 378 | 68 610 |
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 31 520 | −48,76 | ||||
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 2 941 | −91,07 | 31,65 | −949 440 | 93 077 |
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 32 941 | 1 020,06 | 15,38 | 461 400 | 506 633 |
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 61 520 | −32,78 | ||||
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 2 941 | −91,07 | 30,42 | −912 450 | 89 451 |
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 32 941 | 1 020,06 | 15,38 | 461 400 | 506 633 |
2013-05-29 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 25 000 | 25 000 | |||||
2013-04-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −18 400 | 0 | −100,00 | ||||
2013-04-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −7 454 | 0 | −100,00 | ||||
2013-04-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −18 400 | 2 941 | −86,22 | 22,50 | −413 908 | 66 158 |
2013-04-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 18 400 | 21 341 | 625,64 | 6,81 | 125 304 | 145 332 |
2013-04-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 454 | 2 941 | −71,71 | 22,50 | −167 678 | 66 158 |
2013-04-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 454 | 10 395 | 253,45 | 11,12 | 82 888 | 115 592 |
2013-04-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 7 454 | −80,10 | ||||
2013-04-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 2 941 | −91,07 | 22,12 | −663 600 | 65 055 |
2013-04-26 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 32 941 | 1 020,06 | 11,12 | 333 600 | 366 304 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 000 | 0 | −100,00 | 22,10 | −220 967 | ||
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 000 | 0 | −100,00 | 22,10 | −220 967 | ||
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 6,81 | 68 100 | 68 100 | |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 6,81 | 68 100 | 68 100 | |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 000 | 2 941 | −77,27 | 22,10 | −220 967 | 64 986 | |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 12 941 | 340,02 | 11,12 | 111 200 | 143 904 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 47 454 | −38,73 | ||||
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 2 941 | −91,07 | 20,99 | −629 700 | 61 732 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 32 941 | 1 020,06 | 11,12 | 333 600 | 366 304 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 0 | −100,00 | ||||
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 2 941 | −91,07 | 20,01 | −600 180 | 58 838 |
2013-04-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 32 941 | 1 020,06 | 7,26 | 217 800 | 239 152 |
2013-04-08 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 28 782 | 28 782 | 0,46 | 13 125 | 13 125 | ||
2013-02-08 |
|
4 | CYTK |
CYTOKINETICS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 50 000 | 50 000 | |||||
2013-02-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 62 280 | 62 280 | |||||
2013-02-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 10 380 | 10 380 | |||||
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −759 | 2 941 | −20,51 | 14,00 | −10 626 | 41 174 | |
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 715 | 5 145 | −25,00 | ||||
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 715 | 3 700 | 86,40 | ||||
2013-01-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 10 000 | 10 000 | |||||
2013-01-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 10 000 | 10 000 | |||||
2013-01-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | −20 000 | 18 400 | −52,08 | ||||
2012-10-11 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Series A Preferred Stock |
C - Conversion | −6 299 500 | 0 | −100,00 | ||||
2012-10-11 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
P - Purchase | 750 000 | 7 049 500 | 11,91 | 4,00 | 3 000 000 | 28 198 000 | |
2012-10-11 |
|
4 | RGLS |
Regulus Therapeutics Inc.
Common Stock |
C - Conversion | 6 299 500 | 6 299 500 | |||||
2012-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2012-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2012-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 506 | 0 | −100,00 | ||||
2012-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 15,12 | −75 600 | |
2012-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 15,12 | −75 600 | |
2012-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 6,84 | 34 200 | 34 200 | |
2012-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 6,84 | 34 200 | 34 200 | |
2012-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 506 | 1 985 | −55,80 | 15,12 | −37 891 | 30 013 |
2012-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 506 | 4 491 | 126,25 | 6,84 | 17 141 | 30 718 |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 5 000 | −50,00 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 5 000 | −50,00 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 5 000 | −50,00 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to uy) |
M - Exercise | −2 494 | 2 506 | −49,88 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −7 506 | 0 | −100,00 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 15,00 | −75 010 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 15,00 | −75 010 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 5,25 | 26 250 | 26 250 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 5,25 | 26 250 | 26 250 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 15,04 | −75 175 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 15,04 | −75 175 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 6,84 | 34 200 | 34 200 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 6,84 | 34 200 | 34 200 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 1 985 | −71,58 | 15,00 | −75 010 | 29 779 |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 6 985 | 251,89 | 5,25 | 26 250 | 36 671 |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 506 | 1 985 | −55,80 | 15,04 | −37 678 | 29 844 |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 506 | 4 491 | 126,25 | 5,25 | 13 156 | 23 578 |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 494 | 1 985 | −55,68 | 15,04 | −37 497 | 29 844 |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 494 | 4 479 | 125,64 | 6,84 | 17 059 | 30 636 |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −2 000 | 7 506 | −21,04 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 1 985 | −50,19 | 15,00 | −30 000 | 29 775 |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 3 985 | 100,76 | 5,25 | 10 500 | 20 921 |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 5 000 | −66,67 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 5 000 | −66,67 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 5 000 | −66,67 | ||||
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 0 | −100,00 | 15,00 | −150 010 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 0 | −100,00 | 15,00 | −150 010 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 5,25 | 52 500 | 52 500 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 5,25 | 52 500 | 52 500 | |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 1 985 | −83,44 | 15,00 | −150 010 | 29 777 |
2012-09-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 11 985 | 503,78 | 5,25 | 52 500 | 62 921 |
2012-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 6 860 | 6 860 | |||||
2012-01-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 10 000 | 15 000 | 200,00 | ||||
2012-01-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | 10 000 | 15 000 | 200,00 | ||||
2012-01-13 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
G - Gift | −20 000 | 19 506 | −50,63 | ||||
2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 61 749 | 61 749 | |||||
2010-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 63 554 | 63 554 |